Chemcon Speciality ChemicalsQ3 FY21

Chemcon Speciality Chemicals Q3 FY21 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹196.22P/E: 24.0Market Cap: ₹719 CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

No

Order

N/A

Capex

Yes

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • Targeted growth of around 15% to 20% in HMDS volumes (Page 11).
  • Around 30% growth expected in CMIC volumes, plus addition of new products (Page 11).
  • Plan to increase production capacities and real-time production by 30% in FY2022 (Page 16).
  • New products like 4-chlorobutyryl chloride and 2,5-DHT expected to contribute Rs. 75-100 Crores revenue each with less than 1-year capex payback period (Pages 12, 5-6).
  • Expansion plants P8 and P9 to commercialize new and existing products, with P8 commercializing in ~5-5.5 months and P9 in ~12 months (Pages 5, 8).
  • Bromide volumes expected to recover to 60-70% of earlier quarterly levels (~1 million kg) (Page 16).
  • Focus on penetrating new clients, new geographic markets, and ongoing cost efficiencies as growth levers (Page 16).
  • Innovation pipeline includes adding at least 2 new products annually (Page 12).

See what Chemcon Speciality Chemicals management said on margin guidance — free account, 30 seconds.

Fundraise plans

No
  • Chemcon Specialty Chemicals Limited has ongoing capital expenditure projects, specifically plants P8 and P9, funded by IPO proceeds and internal accruals.
  • Rs. 25 Crores of capex has already been incurred, with further expenditure ongoing for these new plants.
  • No explicit mention of any new or future fundraising through additional debt or equity beyond the IPO proceeds used for current expansions.
  • The company is focusing on capacity expansions, new product commercialization, and increasing production volumes funded by internal resources and the IPO.
  • No clear statement on plans for further capital raising was provided in the call.

See what Chemcon Speciality Chemicals management said on order book — free account, 30 seconds.

Capex plans

Yes
  • Ongoing capital expenditure on plants P8 and P9, funded partly by IPO proceeds and internal accruals; about Rs. 25 Crores incurred so far.
  • P8 plant expected to be commercialized in approximately 5 to 5.5 months, and P9 plant around 12 months from the call date (Feb 2021).
  • The new multipurpose plants (P8 & P9) will support existing products and enable manufacturing of new products such as 4-chlorobutyryl chloride, 2,5 DHT, and expanded CMIC capacity.
  • Total volumetric reactor capacity after expansion will be ~625 kl.
  • Future capex beyond P8 & P9 not specifically detailed but focus remains on continuous product additions and capacity expansions.
  • New product additions target revenue sizes of Rs. 75-100 Crores with a payback period of under one year.
  • Strategic emphasis on penetrating new clients, new geographic markets, and ongoing cost efficiencies to drive growth.

Track Chemcon Speciality Chemicals — get its next earnings analysis in your feed

How does Chemcon Speciality Chemicals rank vs peers in Chemicals & Petrochemicals?

Pro feature
ThisChemcon Speciality Chemicals
Rev 3Mar 3

How does Chemcon Speciality Chemicals rank in Chemicals & Petrochemicals?

Compare Chemcon Speciality Chemicals against every Chemicals & Petrochemicals company (Q3 FY21) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Others in Chemicals & Petrochemicals this season

  • Seya Industries (Q2 FY27)

    Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's

  • DCM Shriram Fine Chemicals (Q2 FY27)

    9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri

  • Dhariwalcorp (Q2 FY27)

    For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…

  • Agastya Energy (Q2 FY27)

    For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →